MDMA-Assisted Psychotherapy

Reviewed by the HeyPsych Medical Review Board

Board-certified psychiatrists and mental health professionals

Published September 4, 2026•Updated September 4, 2026•Reviewed September 4, 2026

Indications

Primary Indications

Severe and treatment-resistant PTSDComplex traumaExploratory: depression, social anxiety, substance use

Mechanism

MDMA primarily increases release of serotonin, norepinephrine, and dopamine while promoting oxytocin and prolactin release. It reduces amygdala hyperreactivity and enhances fear extinction, empathy, and trust, facilitating effective trauma processing in psychotherapy.

Protocol

Preparation

3 preparatory therapy sessions focusing on trust, safety, and trauma history.

Procedure

Oral administration of MDMA (75–125 mg, with optional booster) in a supportive environment
Two trained therapists present throughout
Non-directive psychotherapeutic support during dosing
Integration sessions in days following

Frequency: 2–3 MDMA sessions spaced 3–5 weeks apart

Duration: 6–8 hours per session plus integration

Total Treatment Time: Approx. 3–4 months

Expected Outcomes

Immediate

Increased emotional openness
Reduced fear responses
Enhanced therapeutic alliance

Short Term

Symptom reduction in PTSD
Improved sleep and mood stability

Long Term

Sustained PTSD remission
Improved functioning and quality of life

Side Effects

common

Jaw tension
Fatigue next day
Mild anxiety

uncommon

Nausea
Sweating
Transient paranoia

rare

Cardiac complications in at-risk patients
Misuse potential outside controlled settings

Contraindications

absolute

Severe cardiovascular disease
Pregnancy
History of psychotic disorders

relative

Bipolar disorder (risk of mania)
Uncontrolled hypertension

special considerations

Requires therapist dyad trained in MAPS protocol

Research Evidence

Key Studies

Mitchell JM et al., MDMA-assisted therapy for severe PTSD: phase 3 trial (Nature Medicine, 2021)
MAPS-sponsored phase 2 and phase 3 trials with high response and remission rates

Limitations

Requires controlled environments, long-term safety data still accruing

Cost Considerations

typical session cost: Not yet commercially available; projected several thousand USD per session

total treatment cost: Estimated $10,000–$20,000 for full protocol

insurance coverage: Not yet; pending FDA approval

cost effectiveness: Potentially cost-saving compared to lifelong PTSD treatment

ux display: undefined

collapsible: undefined

heading: undefined

Integration Support

Concurrent Therapies

Ongoing psychotherapy
Mindfulness-based therapies
Peer support groups

This treatment information is for educational purposes only. Treatment decisions should be made in consultation with qualified healthcare professionals based on individual circumstances, symptoms, and medical history. Do not attempt treatment without professional guidance.

Interested in this treatment?

This information is for educational purposes. Always consult with a qualified healthcare provider before starting any new treatment.

Locate Psychiatrists